Vanberra Signal

Expansion Therapeutics

Curated by Signal

Provider of a software system for the development of drugs

Overview

Provider of a software system for the development of drugs. The platform is engaged in the development of RNA-based therapeutics for Myotonic Dystrophy by using proprietary technology. The company also has a suite of proprietary validation tools and second-generation chemistries.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of home-based diagnostic tests for the detection of various diseases

    Life Sciences TechnologyAustin, United States
  • Non-invasive fetal heart rate monitor

    Life Sciences TechnologyNorth Andover, United States
  • Provider of machine learning models for drug discovery

    Life Sciences TechnologyCambridge, United States

About Expansion Therapeutics

What does Expansion Therapeutics do?

Provider of a software system for the development of drugs.

Where is Expansion Therapeutics headquartered?

Expansion Therapeutics is headquartered in San Diego, United States.

When was Expansion Therapeutics founded?

Expansion Therapeutics was founded in 2016.

Which sector is Expansion Therapeutics in?

Expansion Therapeutics operates in Life Sciences Technology.

Who are Expansion Therapeutics's competitors?

Companies similar to Expansion Therapeutics include Everlywell, MindChild Medical, and GiwoTech.